Description

Comprehensive Guide to Industrial Grade Fentanyl Powder

 

PRODUCT DETAILS TABLE

---

Fentanyl (N-Phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]propanamide) represents an ultra-potent synthetic opioid analgesic with established pharmaceutical applications in anesthesia, perioperative pain management, and chronic pain treatment (Duragesic®, Actiq®, Sublimaze®). As a full μ-opioid receptor agonist with 50-100 times the potency of morphine, fentanyl serves as a critical reference standard in forensic toxicology, pharmaceutical research, and clinical pharmacology. Biosynlab delivers pharmaceutical-grade fentanyl with certified ≥99.0% purity, supporting cutting-edge research across USA (DEA Schedule II licensed institutions), United Kingdom, European Union, and international scientific and clinical markets.

The unique 4-anilidopiperidine structure of fentanyl distinguishes it from morphinan opioids, conferring high lipophilicity, rapid onset of action, and short duration of effect. These pharmacokinetic properties make fentanyl invaluable for specific clinical applications while requiring extreme caution in handling due to its potency (lethal dose estimated at 2-3mg for opioid-naïve individuals). Biosynlab’s rigorous quality control ensures batch-to-batch consistency essential for quantitative research, therapeutic drug monitoring, and forensic applications where precision is paramount. Research institutions and forensic laboratories in London, Berlin, Amsterdam, New York, and San Francisco rely on Biosynlab fentanyl for quantitative analysis, novel fentanyl analog research, and monitoring of the evolving synthetic opioid landscape.

Chemical Properties & Structural Characterization

Fentanyl belongs to the 4-anilidopiperidine chemical class, a distinct structural scaffold from traditional morphinan opioids, characterized by a piperidine ring with an anilide substitution at the 4-position and a phenethyl group on the piperidine nitrogen.

Key Structural Features:

• Core Scaffold: 4-anilidopiperidine backbone
• Substitutions: N-phenylpropanamide (anilide), N-phenethylpiperidine
• Functional Groups: Tertiary amide, tertiary amine (piperidine), phenyl rings
• Stereochemistry: Achiral molecule (no stereocenters)
• Salt Forms: Citrate (most common), hydrochloride, base
• Physical State: Crystalline powder (highly potent, handle with extreme care)

Analytical Characteristics:

• UV Absorption: 250 nm (anilide chromophore), 280 nm shoulder
• Retention Time (HPLC): 7.2-8.0 minutes (C18 column, gradient method)
• Mass Spec m/z: 337.2 [M+H]+ (base), 188.1 [phenethylpiperidine]+, 105.1 [phenyl]+, 91.1 [tropylium]+
• NMR Signatures: Piperidine protons (1.4-2.8 ppm), phenethyl protons (2.6-2.9 ppm), phenyl protons (7.1-7.4 ppm), N-phenyl multiplet (7.4-7.6 ppm)

Research Applications & Scientific Utility

Opioid Receptor Pharmacology:
Fentanyl serves as a critical tool compound for investigating μ-opioid receptor (MOR) pharmacology. Research applications include:

• μ-Opioid receptor binding affinity determination (Ki ~0.5-2 nM, high affinity)
• Full agonist characterization and efficacy studies
• Structure-activity relationship studies in 4-anilidopiperidines
• Comparison with morphine, sufentanil, alfentanil, and remifentanil
• Receptor selectivity profiling (MOR vs. DOR vs. KOR)
• G-protein coupling and β-arrestin recruitment studies
• Bias agonism and signaling pathway investigations

Forensic Toxicology & Opioid Crisis Research:
Certified reference standard applications include:

• LC-MS/MS method development for ultra-low level detection (pg/mL)
• Post-mortem toxicology case work (overdose investigations)
• Differentiation of pharmaceutical vs. illicitly manufactured fentanyl
• Novel fentanyl analog monitoring (acetylfentanyl, carfentanil, etc.)
• Driving under the influence (DUID) investigations
• Workplace drug testing assay validation
• Illicit sample profiling and comparative analysis

Clinical & Pharmaceutical Research:

• Anesthesia and perioperative pain management studies
• Transdermal delivery system research (Duragesic® patches)
• Buccal and sublingual formulation development (Actiq®, Fentora®)
• Pharmacokinetic studies (rapid onset, short duration)
• Therapeutic drug monitoring (TDM) assay development
• Drug interaction studies (CYP3A4 metabolism)
• Abuse-deterrent formulation research

Novel Fentanyl Analog Research:

• Structure-activity relationships in designer fentanyls
• Potency comparisons and structure-toxicity relationships
• Detection method development for emerging analogs
• International drug surveillance and early warning systems
• Metabolite identification and profiling

Synthesis & Quality Control Protocols

Biosynlab’s fentanyl production adheres to rigorous pharmaceutical-grade standards with extreme safety protocols:

Synthetic Route:

1. Starting Material: 4-piperidone or appropriate precursor (pharmaceutical grade)
2. N-Alkylation: Installation of phenethyl group on piperidine nitrogen
3. Anilide Formation: Reaction with aniline derivative to form propanamide
4. Purification: Multi-step recrystallization and chromatography
5. Salt Formation: Citrate or HCl salt preparation
6. Micronization: Controlled particle size for consistency
7. Drying: Vacuum desiccation under inert atmosphere
8. Packaging: Immediate containment in multiple sealed containers

Analytical Verification:

• HPLC-PDA: Purity ≥99.0%, impurity profiling (analogs, precursors) <0.5%
• ¹H NMR (400 MHz): Complete structural assignment
• ¹³C NMR (100 MHz): Carbon environment verification
• LC-MS/MS: Molecular weight confirmation, fragmentation analysis
• FTIR-ATR: Amide carbonyl (1640-1680 cm⁻¹), aromatic confirmation
• DSC: Melting point determination, thermal stability
• TGA: Thermal gravimetric analysis
• Residual Solvent: GC-HS per ICH Q3C guidelines
• Heavy Metals: ICP-MS for Class 1 and 2 elements
• Water Content: Karl Fischer titration
• Particle Size: Laser diffraction for consistency

Extreme Safety Considerations:

• Potency Warning: Active at microgram doses; lethal at milligram doses
• Dermal Absorption: Transdermal penetration risk; avoid skin contact
• Inhalation Risk: Extremely hazardous if powder becomes airborne
• Cross-Contamination: Rigorous cleaning protocols required

Batch Documentation:

• Certificate of Analysis (COA) with complete analytical data
• Material Safety Data Sheet (MSDS) with extreme hazard warnings
• DEA Form 222 documentation (USA)
• Stability testing data
• Chain of custody documentation

Packaging, Storage & Logistics

Primary Containment (Triple Containment):

• Inner: Sealed amber glass vial (5-20mL)
• Middle: PTFE-lined secondary container with absorbent
• Outer: Rigid impact-resistant container with tamper-evident seals
• Argon headspace to prevent oxidation
• Multiple indicating silica gel desiccant packets
• Emergency spill cleanup materials included

Secondary Packaging:

• Rigid protective containers with custom foam inserts
• Shock-absorbing packaging materials
• Plain unmarked cardboard exterior
• Temperature-controlled packaging
• “Extreme Hazard – Opioid” labeling (for handlers)